Skip to main content
. 2024 Sep 5;9(37):39004–39012. doi: 10.1021/acsomega.4c05592

Figure 8.

Figure 8

Viability of cells from HT-1080 tumor explants versus Suc-Ala-Ala-Pro-Val-anilide-TEMPO: Protection by the ilomastat is preserved for all cells. Eglin C does not protect.